MAYO CLINIC CARE NETWORK:  You are being directed here from the video housed in the Care Network portal.

RELEASE:  January 9, 2017
EXPIRATION:  December 31, 2018 (Credit is not available after this expiration date.)

LEARNING OBJECTIVES:
Recognize the rationale for strategies to slow Parkinson's disease progression
Identify comparative costs of Parkinson's disease (PD) medications
Determine the rationale for initial PD drug treatment selection
Develop a logical strategy for carbidopa/levodopa treatment

ACCREDITATION:
Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  

Mayo Clinic College of Medicine and Science designates this enduring material for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

INSTRUCTIONS:

• Select the Take Course button below.
• Participate in the quiz.  Participants must pass by a minimum of 80%, 1 re-take is allowed.  Quizzes will have between 2-5 questions.
• Complete the evaluation.  

TRANSCRIPT:
This credit will appear on your Transcript for permanent record.  To access your transcript, visit My Account, My Activities, Transcript.

DISCLOSURE SUMMARY
As a provider accredited by ACCME, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities.  Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity.  Safeguards against commercial bias have been put in place.  Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation.  Disclosure of this information will be published in course materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

No relevant financial relationship(s) with industry:

Alan J. Aksamit, M.D.,  Christopher J. Boes, M.D.,  Jeffrey W. Britton, M.D.,  Neeraj Kumar, M.D.,  Ruple S. Laughlin, M.D.,  Claudia F. Lucchinetti, M.D.,  Eric J. Sorenson, M.D., James C. Watson, M.D.,  Shari L. Eversman, Janice A. Klaassen, DeAnna Shones, Eric Cleveland

Relevant financial relationship(s) with industry:

Sara Hocker, M.D. - Honoraria - Continuum, American Academy of Neurology
Lyell Jones, Jr., M.D. - Honoraria - American Academy of Neurology
Erik St. Louis, M.D. - Consultant - Inspire, Inc. (DSMB Committee for RCT); Axovant, Inc.; Grant/Research Support - Mayo Clinic CCaTS, NIH/NHLBI, NINDS
Elaine Wirrell, M.D. - Consultant - Zogenix Medical Advisory Board (all monies to Mayo); Grant/Research Support - Zogenix, GW Pharma (All monies to Mayo)

 No relevant financial relationship(s) with industry:

J. Eric Ahlskog, M.D., Ph.D.

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:

None

QUESTIONS?
Contact:  cme@mayo.edu